Pathogenesis of Choledochal Cyst: Insights from Genomics and Transcriptomics

Area of Science:

• Gastroenterology and Hepatology
• Molecular Biology
• Medical Genetics

Background:

• Choledochal cysts (CC) are congenital dilatations of the bile ducts.
• Current understanding of CC pathogenesis is limited, with theories including pancreaticobiliary maljunction and congenital stenosis.
• The molecular basis of CC, including genetic factors and signaling pathways, remains largely unexplored.

Purpose of the Study:

• To review recent advances in genomics and transcriptomics for understanding choledochal cyst pathogenesis.
• To elucidate the molecular mechanisms underlying CC development.
• To improve clinical management strategies for CC subtypes, focusing on hepatic fibrosis and malignant transformation.

Main Methods:

• Comprehensive review of transcriptomics and genomics studies related to choledochal cysts.
• Analysis of gene expression signatures and signaling pathways implicated in CC.
• Integration of molecular findings with clinical data on CC subtypes.

Main Results:

• Genomics and transcriptomics studies have identified key molecular signatures and pathways in CC pathogenesis.
• These studies provide novel insights into the complex pathomechanisms of CC.
• Evidence suggests specific molecular alterations are associated with hepatic fibrotic changes and malignant potential in CC.

Conclusions:

• Genomic and transcriptomic data offer a deeper understanding of choledochal cyst development.
• This molecular understanding can guide improved clinical management, particularly for CC subtypes with fibrosis and cancer risk.
• Further research integrating multi-omics data is crucial for advancing CC diagnosis and treatment.